MedPath

To assess repigmentation in patients with vitiligo using AVARI (Automated Vitiligo area Repigmentation Index)

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2021/09/036800
Lead Sponsor
Dr Deepti Jaiswal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pre and post treatment images of prospective patients of age group more

than 6 years who are willing to give informed consent for using AVARI on

the images and being photographed

Exclusion Criteria

Patients who refuse to be photographed

Patients unwilling to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main outcome is to evaluate the efficacy of AVARI in <br/ ><br>assessing the repigmentation in vitiligo lesionsTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath